These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4708590)

  • 1. Fibrin-I degradation products with a molecular weight higher than that of fibrinogen. Identification and characterization of in vitro products from human plasma.
    von Hugo R; Graeff H
    Thromb Diath Haemorrh; 1973 Feb; 29(1):122-9. PubMed ID: 4708590
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of fibrinogen derivatives in plasma samples.
    Graeff H; von Hugo R
    Thromb Diath Haemorrh; 1972 Jul; 27(3):610-8. PubMed ID: 4197047
    [No Abstract]   [Full Text] [Related]  

  • 3. [Identification and preparation of high-molecular derivatives of fibrinogen from human plasma by means of PAA-gel electrophoresis and agarose-gel chromatography].
    von Hugo R; Graeff H
    Thromb Diath Haemorrh Suppl; 1973; 55():325-37. PubMed ID: 4216114
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of high molecular weight derivatives of plasmic digests of cross-linked human fibrin.
    Regañon E; Vila V; Aznar J
    Thromb Haemost; 1978 Oct; 40(2):368-76. PubMed ID: 153595
    [No Abstract]   [Full Text] [Related]  

  • 5. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group.
    Dempfle CE; Zips S; Ergül H; Heene DL;
    Thromb Haemost; 2001 Apr; 85(4):671-8. PubMed ID: 11341504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophoretic demonstration of high molecular weight fibrin degradation products persisting in chronic subdural hematomas.
    Toyosawa M; Kashiwagi S; Pei W; Fujisawa H; Ito H; Nakamura K
    Electrophoresis; 1997 Jan; 18(1):118-21. PubMed ID: 9059832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinogen and fibrin degradation products].
    Fujimaki M; Ikematsu S; Kato M
    Rinsho Byori; 1973 Jan; 21(1):31-6. PubMed ID: 4267650
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization and significance of urinary fibrin degradation products.
    Cortes P; Potter EV; Kwaan HC
    J Lab Clin Med; 1973 Sep; 82(3):377-89. PubMed ID: 4199524
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
    Carroll RC; Lockhart MS; Taylor FB
    J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unreliability in the estimation of the molecular weight of fibrinogen degradation products (FDPs) by polyacrylamide/sodium dodecyl sulphate electrophoresis (SDS/PAGE).
    Arocha-Piñango CL; Perales J; Carvajal Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):737-41. PubMed ID: 2416650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
    Tsianos EB; Stathakis NE
    Thromb Haemost; 1980 Dec; 44(3):130-4. PubMed ID: 6162208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibrinogen and its fragments during streptokinase treatment.
    Gaffney PJ; Chesterman CN; Allington MJ
    Br J Haematol; 1974 Feb; 26(2):285-93. PubMed ID: 4210588
    [No Abstract]   [Full Text] [Related]  

  • 13. Degradation of fibrinogen by proteolytic enzymes. I. Characterization and isolation of products and their relation to fibrinolytic states.
    Sanchez-Avalos J; Miller SP
    Thromb Diath Haemorrh; 1968 Jul; 19(3):499-515. PubMed ID: 4974324
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products.
    Niewiarowski S; Gurewich V
    J Lab Clin Med; 1971 Apr; 77(4):665-76. PubMed ID: 4928905
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen heterogeneity in human plasma. Electrophoretic demonstration and characterization of two major fibrinogen components.
    Lipinska I; Lipinski B; Gurewich V
    J Lab Clin Med; 1974 Oct; 84(4):509-16. PubMed ID: 4413464
    [No Abstract]   [Full Text] [Related]  

  • 16. [Identification of a (D-D)...E complex in degradation products of bovine fibrin stabilized by factor XIII].
    Hudry-Clergeon G; Paturel L; Suscillon M
    Pathol Biol (Paris); 1974 Nov; 22 suppl():47-52. PubMed ID: 4620095
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii.
    Malinconico SM; Katz JB; Budzynski AZ
    J Lab Clin Med; 1984 Nov; 104(5):842-54. PubMed ID: 6387015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immuno-nephelometric characterization of fibrinogen derivatives and of fibrin after chromatography].
    Haarsma M; Mensi N; Roth M; Bouvier CA
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1368-9. PubMed ID: 4279067
    [No Abstract]   [Full Text] [Related]  

  • 19. A rapid chromatographic method for quantitation of high molecular weight fibrinogen derivatives in plasma.
    Musumeci V; Culasso D; Boni P
    Thromb Haemost; 1978 Jun; 39(3):555-63. PubMed ID: 705685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nature of fibrinogen B-soluble fibrin monomer complexes precipitable by ethanol and 2-naphthol].
    Zubairov DM; Litvinov RI
    Biokhimiia; 1980 Jun; 45(6):1059-67. PubMed ID: 7213845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.